An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus

[1]  K. Alam,et al.  Elucidating the impact of glucosylation on human serum albumin: A multi-technique approach. , 2016, International journal of biological macromolecules.

[2]  K. Alam,et al.  Hyperglycemia induced structural and functional changes in human serum albumin of diabetic patients: a physico-chemical study. , 2016, Molecular bioSystems.

[3]  K. Alam,et al.  Impact of in vitro non-enzymatic glycation on biophysical and biochemical regimes of human serum albumin: relevance in diabetes associated complications , 2015 .

[4]  J. Ahmad,et al.  Amadori albumin in diabetic nephropathy , 2015, Indian journal of endocrinology and metabolism.

[5]  Nancy,et al.  Glycation of Amino Groups in Protein , 2014 .

[6]  D. Dash,et al.  Amadori glycated proteins: role in production of autoantibodies in diabetes mellitus and effect of inhibitors on non-enzymatic glycation. , 2013, Aging and disease.

[7]  Jamal Ahmad,et al.  Structural and immunological characterization of Amadori-rich human serum albumin: role in diabetes mellitus. , 2012, Archives of biochemistry and biophysics.

[8]  E. Bourdon,et al.  Structural modifications of human albumin in diabetes. , 2012, Diabetes & metabolism.

[9]  D. S. Hage,et al.  High-performance affinity chromatography and the analysis of drug interactions with modified proteins: binding of gliclazide with glycated human serum albumin , 2011, Analytical and bioanalytical chemistry.

[10]  Qibin Zhang,et al.  Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects. , 2011, Journal of proteome research.

[11]  M. Cohenford,et al.  In vitro galactation of human serum albumin: analysis of the protein's galactation sites by mass spectrometry. , 2011, Analytical biochemistry.

[12]  D. S. Hage,et al.  Binding of tolbutamide to glycated human serum albumin. , 2011, Journal of pharmaceutical and biomedical analysis.

[13]  D. S. Hage,et al.  The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan. , 2010, Journal of pharmaceutical and biomedical analysis.

[14]  D. S. Hage,et al.  Chromatographic analysis of acetohexamide binding to glycated human serum albumin. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[15]  W. Khan,et al.  Antibodies against Gluco-Oxidatively Modified Human Serum Albumin Detected in Diabetes-Associated Complications , 2010, International Archives of Allergy and Immunology.

[16]  M. Koga,et al.  A1C but Not Serum Glycated Albumin Is Elevated Because of Iron Deficiency in Late Pregnancy in Diabetic Women , 2009, Diabetes Care.

[17]  Alexander Scherl,et al.  Glycation Isotopic Labeling with 13C-Reducing Sugars for Quantitative Analysis of Glycated Proteins in Human Plasma* , 2009, Molecular & Cellular Proteomics.

[18]  I. Mackay,et al.  Clustering and commonalities among autoimmune diseases. , 2009, Journal of autoimmunity.

[19]  N. Hasan.  Effects of trace elements on albumin and lipoprotein glycation in diabetic retinopathy. , 2009, Saudi medical journal.

[20]  L. Harrison,et al.  Reappraising the stereotypes of diabetes in the modern diabetogenic environment , 2009, Nature Reviews Endocrinology.

[21]  M. Emoto,et al.  Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test. , 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[22]  Moinuddin,et al.  Characterization of hydroxyl radical modified GAD65: A potential autoantigen in type 1 diabetes , 2009, Autoimmunity.

[23]  R. He,et al.  Rapid glycation with D-ribose induces globular amyloid-like aggregations of BSA with high cytotoxicity to SH-SY5Y cells , 2009, BMC Cell Biology.

[24]  H. V. Roohk,et al.  A Review of Glycated Albumin as an Intermediate Glycation Index for Controlling Diabetes , 2008, Journal of diabetes science and technology.

[25]  E. Bourdon,et al.  Oxidative stresses induced by glycoxidized human or bovine serum albumin on human monocytes. , 2008, Free radical biology & medicine.

[26]  Sameer Singh,et al.  Albumin competitively inhibits glycation of less abundant proteins. , 2008, Protein and peptide letters.

[27]  H. Kaneto,et al.  Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. , 2008, Endocrine journal.

[28]  R. Hoffmann,et al.  Analysis of Amadori Peptides Enriched by Boronic Acid Affinity Chromatography , 2008, Annals of the New York Academy of Sciences.

[29]  S. Yamagishi,et al.  Advanced glycation end products and insulin resistance. , 2008, Current pharmaceutical design.

[30]  D. S. Hage,et al.  Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[31]  A. Ohnishi,et al.  Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[32]  G. Wiederschain,et al.  Handbook of affinity chromatography , 2007, Biochemistry (Moscow).

[33]  P. Bondarenko,et al.  Screening and sequencing of glycated proteins by neutral loss scan LC/MS/MS method. , 2007, Analytical chemistry.

[34]  T. Harada,et al.  Glycated Albumin Induces Activation of Activator Protein-1 in Retinal Glial Cells , 2007, Japanese Journal of Ophthalmology.

[35]  R. Hanschke,et al.  Differential expression of fructosyllysine-specific receptors on monocytes and macrophages and possible pathophysiological significance , 1996, Diabetologia.

[36]  M. Ganjali,et al.  Spectroscopic studies of the effects of glycation of human serum albumin on L-Trp binding. , 2007, Protein and peptide letters.

[37]  Kojiro Matsumoto,et al.  Amadori-modified glycated albumin predominantly induces E-selectin expression on human umbilical vein endothelial cells through NADPH oxidase activation. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[38]  N. Tajima,et al.  Glycated albumin is low in obese, non-diabetic children. , 2006, Diabetes research and clinical practice.

[39]  M. Khan,et al.  Hydroxyl radical modification of human serum albumin generated cross reactive antibodies , 2006, Autoimmunity.

[40]  Mirela Pascariu,et al.  Early glycation products of endothelial plasma membrane proteins in experimental diabetes. , 2006, Biochimica et biophysica acta.

[41]  M. Davies,et al.  Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of alpha-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins. , 2005, Chemical research in toxicology.

[42]  M. Howard,et al.  NMR Analysis of Synthetic Human Serum Albumin α-Helix 28 Identifies Structural Distortion upon Amadori Modification* , 2005, Journal of Biological Chemistry.

[43]  Paul J Thornalley,et al.  Peptide Mapping of Human Serum Albumin Modified Minimally by Methylglyoxal in Vitro and in Vivo , 2005, Annals of the New York Academy of Sciences.

[44]  K. Nair,et al.  Identification of Amadori-modified plasma proteins in type 2 diabetes and the effect of short-term intensive insulin treatment. , 2005, Diabetes care.

[45]  Paul J Thornalley,et al.  Peptide Mapping Identifies Hotspot Site of Modification in Human Serum Albumin by Methylglyoxal Involved in Ligand Binding and Esterase Activity* , 2005, Journal of Biological Chemistry.

[46]  P. Traldi,et al.  Importance of measuring products of non-enzymatic glycation of proteins. , 2005, Clinical biochemistry.

[47]  S. L. Jeffcoate,et al.  Diabetes control and complications: the role of glycated haemoglobin, 25 years on , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[48]  Domenico Fedele,et al.  Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides , 2004, Journal of the American Society for Mass Spectrometry.

[49]  F. Ziyadeh,et al.  Effects of glycated albumin on mesangial cells: evidence for a role in diabetic nephropathy , 1993, Molecular and Cellular Biochemistry.

[50]  E. Van Obberghen,et al.  Human Glycated Albumin Affects Glucose Metabolism in L6 Skeletal Muscle Cells by Impairing Insulin-induced Insulin Receptor Substrate (IRS) Signaling through a Protein Kinase Cα-mediated Mechanism* , 2003, Journal of Biological Chemistry.

[51]  Toru Maruyama,et al.  The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants. , 2003, Biochimica et biophysica acta.

[52]  P. Liss,et al.  Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension , 2003, Diabetologia.

[53]  Sheldon Chen,et al.  Glycated albumin increases oxidative stress, activates NF-kappa B and extracellular signal-regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-beta 1 production in macrophage RAW cells. , 2003, The Journal of laboratory and clinical medicine.

[54]  V. Monnier,et al.  Methylglyoxal-bovine serum albumin stimulates tumor necrosis factor alpha secretion in RAW 264.7 cells through activation of mitogen-activating protein kinase, nuclear factor kappaB and intracellular reactive oxygen species formation. , 2003, Archives of biochemistry and biophysics.

[55]  T W Evans,et al.  Review article: albumin as a drug—biological effects of albumin unrelated to oncotic pressure , 2002, Alimentary pharmacology & therapeutics.

[56]  Paul J Thornalley,et al.  Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence. , 2002, The Biochemical journal.

[57]  Paul J Thornalley,et al.  Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl)lysine-modified albumin. , 2002, The Biochemical journal.

[58]  C. Stehouwer,et al.  Pathophysiological role of Amadori-glycated proteins in diabetic microangiopathy. , 2002, Seminars in vascular medicine.

[59]  P. Matzinger.  The Danger Model: A Renewed Sense of Self , 2002, Science.

[60]  Y. Hattori,et al.  Vascular Smooth Muscle Cell Activation by Glycated Albumin (Amadori Adducts) , 2002, Hypertension.

[61]  H. Saya,et al.  Study of autoantibodies against advanced glycation endproducts of the Maillard reaction , 2001 .

[62]  C. Shearman,et al.  Identification of calnexin as a binding protein for Amadori-modified glycated albumin. , 2001, Biochemical and biophysical research communications.

[63]  A. Poljak,et al.  Fluorometric and mass spectrometric analysis of nonenzymatic glycosylated albumin. , 2001, Biochemical and biophysical research communications.

[64]  M. Kitahara,et al.  Tumor necrosis factor-α is induced through phorbol ester- and glycated human albumin-dependent pathway in THP-1 cells , 2001 .

[65]  G. Siest,et al.  Increased protein glycation in cerebrospinal fluid of Alzheimer’s disease 2 2 Abbreviations: AD, Alzheimer’s disease; AGEs, advanced glycation end products; apo, apolipoprotein; BSA, bovine serum albumin; CSF, cerebrospinal fluid; ELISA, enzyme-linked immunosorbent assay; PBS, phosphate buffe , 2001, Neurobiology of Aging.

[66]  Y. Hattori,et al.  Glycated serum albumin-induced vascular smooth muscle cell proliferation through activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by protein kinase C. , 2001, Biochemical and biophysical research communications.

[67]  N A Mitchison,et al.  Tolerance and Autoimmunity , 2001 .

[68]  L. Bry,et al.  Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. , 2001, Clinical chemistry.

[69]  M. Kitahara,et al.  Tumor necrosis factor-alpha is induced through phorbol ester--and glycated human albumin-dependent pathway in THP-1 cells. , 2001, Cellular signalling.

[70]  N. Turk,et al.  Detection of autoantibodies against advanced glycation endproducts and AGE-immune complexes in serum of patients with diabetes mellitus. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[71]  A. Gugliucci.  Glycation as the glucose link to diabetic complications , 2000, The Journal of the American Osteopathic Association.

[72]  F. Ziyadeh,et al.  Amadori-glycated albumin in diabetic nephropathy: pathophysiologic connections. , 2000, Kidney international. Supplement.

[73]  F. Ziyadeh,et al.  Inhibiting Albumin Glycation Ameliorates Diabetic Nephropathy in the db/db Mouse , 2000, Nephron Experimental Nephrology.

[74]  A. Schmidt,et al.  Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. , 1999, Circulation research.

[75]  E. Bourdon,et al.  Glucose and free radicals impair the antioxidant properties of serum albumin , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[76]  P. B. Chock,et al.  Oxidation-Reduction Properties of Methylglyoxal-modified Protein in Relation to Free Radical Generation* , 1998, The Journal of Biological Chemistry.

[77]  R. Holman,et al.  UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes , 1997, The Lancet.

[78]  Paul J Thornalley,et al.  Synthesis and secretion of tumour necrosis factor-alpha by human monocytic THP-1 cells and chemotaxis induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts. , 1997, Immunology letters.

[79]  A. Schmidt,et al.  Activation of the Receptor for Advanced Glycation End Products Triggers a p21 ras -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress* , 1997, The Journal of Biological Chemistry.

[80]  P. Drouin,et al.  Role of Albumin Glycation on the Erythrocyte Aggregation: An In Vitro Study , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[81]  G. Paolisso,et al.  Oxidative Stress and Diabetic Vascular Complications , 1996, Diabetes Care.

[82]  D. Suzuki,et al.  Localization of glycated proteins in the glomeruli of patients with diabetic nephropathy. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[83]  P. Guillausseau,et al.  Rapid Publication , 1971, Nature.

[84]  J. Baynes,et al.  N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. , 1995, Biochemistry.

[85]  M. Brownlee.  The pathological implications of protein glycation. , 1995, Clinical and investigative medicine. Medecine clinique et experimentale.

[86]  Paul J Thornalley,et al.  Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins , 1995, Journal of protein chemistry.

[87]  J. Baynes,et al.  Chemistry of the fructosamine assay: D-glucosone is the product of oxidation of Amadori compounds. , 1994, Clinical chemistry.

[88]  V. Monnier,et al.  ELISA of pentosidine, an advanced glycation end product, in biological specimens. , 1994, Clinical chemistry.

[89]  M. Cohen,et al.  Amelioration of diabetic nephropathy by treatment with monoclonal antibodies against glycated albumin. , 1994, Kidney international.

[90]  Y. Zou,et al.  Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. , 1994, The Journal of biological chemistry.

[91]  F. Ziyadeh,et al.  Amadori glucose adducts modulate mesangial cell growth and collagen gene expression. , 1994, Kidney international.

[92]  N. Okabe,et al.  Drug binding properties of glycosylated human serum albumin as measured by fluorescence and circular dichroism. , 1994, Biological & pharmaceutical bulletin.

[93]  L. Groop,et al.  Antibodies to Glutamic Acid Decarboxylase Reveal Latent Autoimmune Diabetes Mellitus in Adults With a Non—Insulin-Dependent Onset of Disease , 1993, Diabetes.

[94]  M. Stern.  Kelly West Lecture: Primary Prevention of Type II Diabetes Mellitus , 1991, Diabetes Care.

[95]  D. Robb,et al.  Identification of glycation at the N-terminus of albumin by gas chromatography-mass spectrometry. , 1989, The Biochemical journal.

[96]  L. Chylack,et al.  Spectroscopic study on the effects of nonenzymatic glycation in human alpha-crystallin. , 1987, Investigative ophthalmology & visual science.

[97]  R. Flückiger,et al.  Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites. , 1986, The Journal of biological chemistry.

[98]  J. Baynes,et al.  Glycation of amino groups in protein. Studies on the specificity of modification of RNase by glucose. , 1985, The Journal of biological chemistry.

[99]  H. Bunn,et al.  Nonenzymatic glycosylation of human serum albumin alters its conformation and function. , 1984, The Journal of biological chemistry.

[100]  A. Bassiouny,et al.  Glucosylated Collagen Is Antigenic , 1983, Diabetes.

[101]  R. Garlick,et al.  The principal site of nonenzymatic glycosylation of human serum albumin in vivo. , 1983, The Journal of biological chemistry.

[102]  E. Schleicher,et al.  Specific Quantitation by HPLC of Protein (Lysine) Bound Glucose in Human Serum Albumin and Other Glycosylated Proteins , 1981, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[103]  J. Baynes,et al.  Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[104]  J. Baynes,et al.  Nonenzymatically glucosylated albumin. In vitro preparation and isolation from normal human serum. , 1979, The Journal of biological chemistry.

[105]  V. J. Stevens,et al.  Diabetic cataract formation: potential role of glycosylation of lens crystallins. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[106]  W. Irvine,et al.  CLINICAL AND PATHOGENIC SIGNIFICANCE OF PANCREATIC-ISLET-CELL ANTIBODIES IN DIABETICS TREATED WITH ORAL HYPOGLYCÆMIC AGENTS , 1977, The Lancet.

[107]  Simpson Ca.  ADAPTATION TO THE DESERT. , 1964 .